ArticleOncotarget2017

Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status.

Jun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.